Patients are the lifeblood of clinical trials. Collecting their data is a necessary step in determining the efficacy and safety of an intervention. However, keeping patients informed and engaged is equally important—and the very essence of the patient-centricity movement. There is an opportunity for mobile apps to make patients feel like “partners” in their clinical trial rather than “generators of data.
There’s also a growing body of evidence demonstrating the promise of mobile technology to boost patient compliance and reduce study dropout rates. Jeff Lee, CEO of mProve Health, a company that develops innovative, mobile patient technologies for life science companies, sat down with The Journal of mHealth to talk about how mobile apps are being used in clinical trials.
Click here to continue reading the full interview >>
